Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04909359 · ClinicalTrials.gov registry record
Characterization of CD Responders to Vedolizumab
A clinical trial, sponsored by University of Miami.
- Completed
- Registry status
- 51
- Enrollment target
NCT04909359: Completed study, sponsored by University of Miami.
NCT04909359 is a clinical trial that has completed, run by University of Miami. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04909359 has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to characterize which patients with Crohn's disease are likely to respond to standard of care to vedolizumab therapy.
Primary Outcome
Evaluated from peripheral blood samples and lamina propria biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-08-25 |
| Est. Completion | 2020-05-18 |
What the finished NCT04909359 record still lists
NCT04909359 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04909359 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04909359 about?
NCT04909359 is a clinical study titled "Characterization of CD Responders to Vedolizumab". The purpose of this study is to characterize which patients with Crohn's disease are likely to respond to standard of care to vedolizumab therapy.
What is the current status of trial NCT04909359?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2015-08-25. Estimated completion is 2020-05-18.
Who is sponsoring clinical trial NCT04909359?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI